2021 Year in Review - Breast Cancer

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

JHOP Print Edition

JHOP Weekly e‑Newsletter

I have reviewed and consent to the terms of JHOP's Privacy Policy, and JHOP has my permission to retain my information in its database, and to forward pertinent communications to me.

Breast Cancer

2021 Breast Cancer Year in Review Introduction

Breast Cancer

Highlights in Breast Cancer from ASCO 2021: An Interview with Virginia Kaklamani, MD

Breast Cancer

Polyunsaturated Fatty Acids, Exercise, and Fatigue in Breast Cancer

Breast Cancer

A Web-Based Survey on Suggested Modifications in the Management of Patients with Breast Cancer During the COVID-19 Pandemic

Breast Cancer

Real-World Patient-Reported Outcomes, Clinical Profile, and Treatment Patterns in a Subset of Patients with HR-Positive, HER2-Negative, Advanced Breast Cancer with Poor Prognostic Factors

Breast Cancer

Overall Survival in Patients with HR-Positive, HER2-Negative, Advanced or Metastatic Breast Cancer Treated with a CDK4/6 Inhibitor plus Fulvestrant: An FDA Pooled Analysis

Breast Cancer

A Summary of PARP Inhibitors for the Treatment of Breast Cancer

Breast Cancer

CDK4/6 Inhibitor Treatment Patterns and Outcomes in Metastatic Breast Cancer by Germline BRCA Mutation Status: A Real-World Evidence Study

Breast Cancer

Olaparib Monotherapy in Germline BRCA Mutation–Positive, HER2-Negative Metastatic Breast Cancer in the Real-World Setting

Breast Cancer

Real-World Tumor Response of Palbociclib plus Letrozole versus Letrozole for Metastatic Breast Cancer in US Clinical Practice

Page 1 of 3
Results 1 - 10 of 28